Hydrochloric Acid

Hydrochloric Acid

SCHEMBL9874572

Cl.O=C(O)C=Cc1cccs1

nearest known ligand 0.96

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
GLA known ✓ P06280 1/20 0.53
HCAR2 Q8TDS4 1/20 0.96
ABCG2 Q9UNQ0 2/20 0.57
SMN1; SMN2 Q16637 5/20 0.56
ALDH1A1 P00352 4/20 0.56
LMNA P02545 3/20 0.56
MAPT P10636 3/20 0.56
RAB9A P51151 4/20 0.53
MEN1 O00255 3/20 0.53
KMT2A Q03164 3/20 0.53
KDM4E B2RXH2 2/20 0.53
NPC1 O15118 2/20 0.53
PSMD14 O00487 1/20 0.53
TP53 P04637 1/20 0.53
HTT P42858 1/20 0.53
HPGD P15428 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL27913308 1.00 HCAR2 (0.96) HCAR2ABCG2SMN1; SMN2ALDH1A1LMNA
SCHEMBL143282 0.98 HCAR2 (1.00) HCAR2ABCG2SMN1; SMN2ALDH1A1LMNA
SCHEMBL600082 0.98 HCAR2 (1.00) HCAR2ABCG2SMN1; SMN2ALDH1A1LMNA
SCHEMBL4212112 0.96 HCAR2 (0.96) HCAR2ABCG2SMN1; SMN2ALDH1A1LMNA
SCHEMBL31591277 0.91 HCAR2 (0.86) HCAR2ABCG2SMN1; SMN2ALDH1A1LMNA
SCHEMBL9117065 0.85 HCAR2 (0.76) HCAR2ABCG2SMN1; SMN2ALDH1A1LMNA
Hydrochloric Acid SCHEMBL27931367 0.84 HCAR2 (0.69) HCAR2ABCG2SMN1; SMN2ALDH1A1LMNA
SCHEMBL5598741 0.83 HCAR2 (0.74) HCAR2ABCG2SMN1; SMN2ALDH1A1LMNA
SCHEMBL5598744 0.83 HCAR2 (0.74) HCAR2ABCG2SMN1; SMN2ALDH1A1LMNA
SCHEMBL9580713 0.83 HCAR2 (0.73) HCAR2ABCG2SMN1; SMN2ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101139089-B Method for preparing amphipathic block polymer decorated nanometer-carbon tube UNIV TONGJI 2010-07-14 CN claimed
CN-101139089-A Method for preparing amphipathic nature block polymer decorated nanometer-carbon tube UNIV TONGJI (CN) 2008-03-12 CN claimed
CN-113912769-A Temperature-resistant salt-tolerant gel foam system and preparation method and application thereof 中国石油化工股份有限公司 2022-01-11 CN disclosed
CN-103232429-A Preparation method of (E)-N-[3-(methylamino)propyl]-3-(thiophene-2-yl) acrylamide and salt thereof Shaoxing minsheng pharmaceutical co ltd 2013-08-07 CN disclosed
CN-103214472-A Preparation of two novel non-ATP (Adenosine Triphosphate) competitive FGFR1 (Fibroblast Growth Factor Receptor1) inhibitors and anti-tumor activity of two novel non-ATP competitive FGFR1 inhibitors WENZHOU MEDICAL COLLEGE 2013-07-24 CN disclosed
CN-101365681-B Iminopropene compound and use thereof SUMITOMO CHEMICAL CO 2013-01-02 CN disclosed
CN-101139089-B Method for preparing amphipathic block polymer decorated nanometer-carbon tube UNIV TONGJI 2010-07-14 CN disclosed
CN-101365681-A Iminopropene compound and use thereof SUMITOMO CHEMICAL CO (JP) 2009-02-11 CN disclosed
CN-101139089-A Method for preparing amphipathic nature block polymer decorated nanometer-carbon tube UNIV TONGJI (CN) 2008-03-12 CN disclosed
US-5011928-A Analgesic and antiinflammatory derivatives of 1-acyl-4-arylalkylpiperazines FABRICA ESPANOLA DE PRODUCTOS QUIMICOS Y FARMECEUTI COS S.A. (FAES) (ES) 1991-04-30 US disclosed
EP-0079049-B1 NOVEL SUBSTITUTED ALKANOYLIMIDAZOL-2-ONE DERIVATIVES MERRELL DOW PHARMACEUTICALS INC. (US) 1987-04-01 EP disclosed
US-4447619-A CARDIOTONIC AGENTS MERRELL DOW PHARMACEUTICALS INC. (US) 1984-05-08 US disclosed
EP-0079049-A2 Novel substituted alkanoylimidazol-2-one derivatives MERRELL DOW PHARMACEUTICALS INC. (US) 1983-05-18 EP disclosed
US-4367236-A CARDIOTONIC AGENTS MERRELL DOW PHARMACEUTICALS INC. (US) 1983-01-04 US disclosed